Biliary cystadenoma (biliary mucinous cystic neoplasm) is a rare cystic neoplasm of the liver presenting as a multilocular, septated cystic mass. Divided into two groups based on presence of ovarian-like mesenchymal stroma: (1) With ovarian-like stroma — almost exclusively in women (95%), middle age, low malignancy potential; (2) Without ovarian-like stroma — both sexes, high malignancy potential (increased cystadenocarcinoma transformation risk). Renamed 'mucinous cystic neoplasm' in WHO 2019 classification. Located intrahepatic (85%) or less commonly extrahepatic. Does not communicate directly with bile ducts — an important differential diagnostic criterion.
Age Range
30-70
Peak Age
50
Gender
Female predominant
Prevalence
Rare
The origin of biliary cystadenomas is debated; thought to arise from ectopic ovarian-like stromal cells or peribiliary glands. In the ovarian-like stroma type, mesenchymal stroma expresses estrogen and progesterone receptors — explaining female dominance and hormonal modulation. Neoplastic epithelial cells produce mucin filling the cyst lumen and forming internal septations. Septations contain vascularized connective tissue and show enhancement. Cyst fluid is mucinous and proteinaceous unlike serous fluid in simple cysts — reflected as mild T1 hyperintensity and internal echogenicity on US. In malignant transformation (cystadenocarcinoma), mural nodules and papillary projections develop — these solid components show neovascularization and enhance. Without ovarian-like stroma, malignant transformation risk is much higher (30-40%) and this type is considered a premalignant lesion requiring surgical resection.
Multilocular, septated, hyperintense cystic mass on MRI in the liver as an independent structure without communication with bile ducts. Septae show enhancement. Mucinous fluid gives higher T1 signal than simple cyst. In middle-aged women, this pattern is highly suggestive of biliary mucinous cystic neoplasm.
Multilocular septated cystic mass on T2-weighted images — cyst compartments are markedly hyperintense (mucinous fluid), septae appear as hypointense thin lines. Signal intensity differences between compartments may be present (different protein concentrations). Mass is usually well-circumscribed, round/oval, intrahepatic. No communication with bile ducts.
Report Sentence
Multilocular septated cystic mass in the liver is noted with T2 hyperintense compartments; consistent with biliary mucinous cystic neoplasm.
Cyst fluid shows higher signal than simple cyst on T1-weighted images — intermediate-hyperintense due to proteinaceous/mucinous content. Signal intensity differences between compartments (different protein/mucin concentrations) are characteristic. Hemorrhagic compartments may be markedly T1 hyperintense. On contrast-enhanced series, septae and cyst wall enhance while cyst fluid does not.
Report Sentence
Fluid content of the cystic mass shows higher T1 signal than simple cyst consistent with proteinaceous/mucinous content; septae demonstrate enhancement.
Multilocular cystic mass on portal venous phase — fluid-density compartments (10-30 HU, proteinaceous), enhancing septae and wall. Septae are thin and smooth (benign) or thick and irregular (suspicious for malignant transformation). Mural nodules or papillary projections enhance and favor cystadenocarcinoma. Mass is usually well-circumscribed, encapsulated.
Report Sentence
Multilocular cystic mass with enhancing septae in the liver is noted; consistent with biliary mucinous cystic neoplasm.
Multilocular cystic mass in liver parenchyma on US — echogenic septae between anechoic/hypoechoic compartments. Internal echogenicity (mucinous debris) may be present. Mural nodules appear as solid echogenic foci. Mass is well-circumscribed, round/oval. Distinguished from simple cyst by septations, from hydatid cyst by more irregular septation pattern and absence of scoleces.
Report Sentence
Multilocular cystic mass with septations in the liver suggestive of biliary cystic neoplasm; MRI recommended for further evaluation.
Enhancing mural nodule or papillary projection in cyst wall or septations on arterial phase — most critical finding for malignant transformation (cystadenocarcinoma). Nodules usually 5-20 mm, showing prominent arterial enhancement. In cases without nodules, smooth thin septal enhancement suggests benign cystadenoma. Mural nodule presence strengthens surgical resection indication.
Report Sentence
Enhancing mural nodule in the cystic mass septation on arterial phase should be evaluated for cystadenocarcinoma transformation; surgical resection recommended.
MRCP demonstrates no communication between cystic mass and biliary tree — no connection with dilated ducts. This is an important distinguishing finding from Caroli disease (saccular dilatation communicates with bile ducts) and secondary cystic dilatation due to biliary obstruction. Mass may displace bile ducts but no direct luminal connection exists.
Report Sentence
MRCP demonstrates no communication between the cystic mass and biliary tree; this finding supports the diagnosis of biliary mucinous cystic neoplasm.
Criteria
Ovarian-like mesenchymal stroma on pathology (estrogen/progesterone receptor positive). Almost exclusively in women (95%), age 40-60. Low malignancy potential. Intrahepatic location. Surgical resection is curative, recurrence is rare (5-10%).
Distinct Features
Thin smooth septae, mural nodules rare, proteinaceous fluid, female patient, good prognosis.
Criteria
No ovarian-like stroma on pathology. Both sexes. High malignancy potential — cystadenocarcinoma transformation risk 30-40%. More aggressive course, more frequent mural nodules and papillary projections.
Distinct Features
Thick irregular septae, mural nodules more frequent, may occur in male patient, high malignant transformation risk.
Criteria
Invasive carcinoma developing in cystadenoma background. Enhancing mural nodules, papillary projections, thick irregular septae. Elevated CA 19-9 and CEA in cyst fluid. Diffusion restriction in nodules on DWI. Local invasion and metastasis potential.
Distinct Features
Prominent enhancing solid component (>10 mm), DWI restriction, thick irregular wall/septae, lymphadenopathy, invasion findings.
Distinguishing Feature
In Caroli disease, cystic dilatations communicate with bile ducts + central dot sign present. In biliary cystadenoma, there is no communication with bile ducts — independent cystic mass.
Distinguishing Feature
Choledochal cyst is dilatation of the bile duct itself and continues with the duct. Biliary cystadenoma is a multilocular cystic mass independent of the bile duct.
Distinguishing Feature
Intrahepatic cholangiocarcinoma shows dominant solid mass + obstructive biliary dilatation. Biliary cystadenoma is a dominant cystic mass with solid component only prominent in malignant transformation.
Distinguishing Feature
Acute cholangitis shows diffuse duct dilatation + wall enhancement + clinical findings (fever, jaundice). Biliary cystadenoma is a focal cystic mass without acute inflammatory findings.
Urgency
urgentManagement
surgicalBiopsy
Not NeededFollow-up
specialist-referralSurgical resection (complete excision) is the standard treatment for biliary cystadenomas due to malignancy potential. Biopsy is contraindicated — incomplete excision increases recurrence and malignant transformation risk. Aspiration is inadequate and recurrence is inevitable. After complete excision in the ovarian-like stroma type, prognosis is excellent (5-year survival >95%). Prognosis is worse in the non-stromal type and cystadenocarcinoma. Mural nodule presence increases surgical urgency. Preoperative MRCP should confirm absence of fistula/communication and guide surgical planning.
Biliary cystadenoma has premalignant potential and requires surgical resection. Drainage or aspiration is insufficient (high recurrence rate). Cystadenocarcinoma should be excluded in the presence of mural nodularity. Complete resection is curative.